Finally, the fact that we used pretherapeutic tumor biopsies for immunohistochemical SEC62 staining might lead to a sampling bias as we could not take into account a potential intra-tumoral heterogeneity of SEC62 expression. The gene discussed is SEC62; the disease is neoplasm.